Distinct Impact of RNF213 p.R4810K Genotype on Transdural Collateral Formation Across Japanese Asian and Polish Caucasian Moyamoya Patients
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Interethnic differences in natural transdural collaterals—an angiographical hallmark of Moyamoya disease (MMD)—may reflect underlying genetic variation. However, comparative studies incorporating both angiographic and genetic data are limited. This study investigated differences in cerebral angioarchitecture and clinical presentation between Japanese Asian and Polish Caucasian patients with MMD, with a focus on the RNF213 p.R4810K variant, a known East Asian founder mutation. We retrospectively analyzed 94 Japanese and 33 Polish patients who underwent diagnostic cerebral angiography and RNF213 p.R4810K genotyping between 2015 and 2025. Suzuki’s angiographical stages and the presence of natural-transdural, periventricular, and posterior cerebral artery (PCA) collaterals were evaluated. Interethnic comparisons included adjustments for RNF213 p.R4810K genotype. The RNF213 p.R4810K wild-type was present in 31% of Japanese and 100% of Polish patients. A trend toward more hemorrhagic presentation in Japanese was noted (17% vs. 12%, P=0.10). Polish patients were significantly younger at diagnosis (P=0.001). Among 230 un-operated hemispheres, angiographic stages did not significantly differ (P=0.31). After adjustment, overall prevalence of natural transdural collaterals was similar (P=0.20), but significantly higher in Polish than in Japanese RNF213 wild-type patients (P=0.0098). Periventricular collaterals were significantly more common in Japanese, independent of genotype (P<0.0001). No interethnic difference was observed in PCA collaterals (P>0.99). In conclusion, Polish MMD patients exhibit more natural transdural and fewer periventricular collaterals than Japanese RNF213 wild-type patients. These differences suggest distinct mechanisms of collateral formation across ethnic groups, with implications for genotype-driven pathophysiology and clinical presentation in MMD.